ProfNet Experts Available on DACA, President Trump's Strategy, More

NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Below are experts from the ProfNet network who are available to discuss timely issues in your coverage area.

You can also submit a query to the hundreds of thousands of experts in our network – it's easy and free. Just fill out the query form to get started: http://prn.to/queryform

EXPERT ALERTS

• Federal Judge Blocks Trump's Phaseout of DACA
• Why President Trump's Strategy Must Be Challenged
• R&D Support for Parkinson's and Alzheimer's

MEDIA JOBS

• Reporter/Editor/Researcher – A Team (Home)
• Reporter – International Trade Today (DC)
• Creative Director, Editorial Lab – Wall Street Journal (NY)

OTHER NEWS & RESOURCES

• Our 2018 Blogging Resolutions
• Media Insider: Glamour's New Editor-in-Chief, Facebook Tests New App for Local News
• Blog Profiles: Organizational Blogs

-------------------------------------------------------------------

EXPERT ALERTS:

Federal Judge Blocks Trump's Phaseout of DACA
Lua Yuille
Associate Professor of Law
University of Kansas School of Law
Yuille can discuss a federal judge blocking President Trump's phaseout of DACA, immigration law, DREAMERS, immigration and appeals of the ruling. Yuille said the decision will "keep DACA partially alive for its existing recipients, which is an important but small victory in what will continue to be an uphill battle for meaningful immigration reform in the country's undocumented communities."
Contact: Mike Krings, [email protected]

Why President Trump's Strategy Must Be Challenged
Harlan Ullman
Chairman
The Killowen Group
Dr. Ullman recently penned a piece for UPI on President Trump's strategy: "As with his recognition of Jerusalem as Israel's capital, the president received nothing in return other than the thanks of Benjamin Netanyahu and other pro-Israeli supporters. No strategy or plan was apparent to underwrite this unilateral and very unwise decision. But the president seems to respond viscerally and without any consideration of the consequences. For those anti-Trumpists particularly in the so-called 'resistance,' these latest tantrums and outbursts create an opportunity. To defeat the Trump agenda, the president must be isolated from his base. Partisan politics will not help. The more Democrats express anger, the more likely will this congeal presidential support from his base." (Full article: https://tinyurl.com/yd62tzu5)
Based in Washington, D.C., Ullman chairs the Killowen Group, which advises leaders of government and business at the highest levels, including presidential candidates here and abroad, through a brains-based approach to strategic thinking. He is a former naval officer with combat commands in the Vietnam War and later in the Persian Gulf, and has developed a reputation as a strategic thought leader and thinker in the public and private sectors. He is known for the doctrine of shock and awe and sits on advisory boards for the Supreme Allied Commander Europe and Commander US Forces Europe. Currently a senior advisor to the Atlantic Council and Business Executives for National Security, he was a Distinguished Senior Fellow at the National Defense University and professor of military strategy at the National War College. A student and practitioner of global economies, he writes often on the financial crises in UPI and other media, and sits on the boards of both private and public companies in the high-tech and financial services sectors. He is also the author of "Anatomy of Failure."
Previous TV clip: https://www.youtube.com/watch?v=iGP9BJtfylY
Website: http://harlanullman.net
Contact: Ryan McCormick, [email protected]

R&D Support for Parkinson's and Alzheimer's
Christopher Bishop
Professor of Psychology
Binghamton University
Pfizer's announcement to halt support for research and development into Parkinson's disease and Alzheimer's disease comes at a difficult time for the several million patients that currently suffer from these devastating neurodegenerative diseases, according to Bishop. This is compounded by the burgeoning elderly population, as new diagnoses are only expected to rise in the years to come. Says Bishop: "Yet, this trend of divestment is not new for large pharmaceutical companies like Pfizer, who have found neurodegenerative diseases like Parkinson's and Alzheimer's either to be intractable to traditional pharmacological approaches or have had difficulty improving upon mainstay drugs. It remains to be seen how this strategic change in research and development by a major industry player will alter the trajectory towards treatments or cures, but it is clear that bolstering other sources of research will be paramount. Although the current Trump administration has threatened to cut medical research support, Congress has been largely supportive. In addition, companies like Pfizer have stated they will continue to invest in venture endeavors that might spawn new approaches for the future."
Bishop is currently conducting Parkinson's research that focuses not only on the treatment of the disease, but also in the side effects of treatment. Current projects, funded by the National Institute of Neurological Disease and Stroke and the Michael J. Fox Foundation, investigate neuroplasticity in the brain serotonin system that may provide a novel target for the reduction of Parkinsonian symptoms and side effects that occur as a result of chronic drug therapy.
Website: https://www.binghamton.edu
Contact: John Brhel, [email protected]

****************

MEDIA JOBS:

Following are links to job listings for staff and freelance writers, editors and producers. You can view these and more job listings on our Job Board: https://prnmedia.prnewswire.com/community/jobs/

• Reporter/Editor/Researcher – A Team (Home)
• Reporter – International Trade Today (DC)
• Creative Director, Editorial Lab – Wall Street Journal (NY)

*****************

OTHER NEWS & RESOURCES:

Following are links to other news and resources we think you might find useful. If you have an item you think other reporters would be interested in and would like us to include in a future alert, please drop us a line at [email protected]

• OUR 2018 BLOGGING RESOLUTIONS: Every January, we start the new year focused on what we'd like to change or do better with our writing and blogging. It's our way of checking in to make sure we're where we want to be personally, professionally and, frankly, with our blog. Here's where our heads are as we gear up for another year on Beyond Bylines: http://prn.to/2Fq8j23
• MEDIA INSIDER: GLAMOUR NAMES NEW EDITOR-IN-CHIEF, FACEBOOK TESTS NEW APP FOR LOCAL NEWS. Media Insider is PR Newswire's roundup of media stories from the week. In this week's edition, we look at Glamour's new editor-in-chief; Facebook's new app specifically for local news and events; BBC's news editor quitting her post to protest gender pay gap; and more: http://bit.ly/2ARpiqG
• BLOG PROFILES: ORGANIZATIONAL BLOGS. Each week, PR Newswire's Audience Relations team selects an industry/subject and profiles a handful of sites that do a good job with promoting and contributing to the conversation. This week, they look at a few organizational blogs: http://prn.to/2mtwXqw

****************

PROFNET is an exclusive service of PR Newswire.

To contact ProfNet: [email protected] or 800-776-3638, ext. 1

SOURCE ProfNet

Related Links

http://www.profnet.com